Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000705150 | SCV000834135 | uncertain significance | DNA ligase IV deficiency | 2022-10-05 | criteria provided, single submitter | clinical testing | This sequence change replaces serine, which is neutral and polar, with asparagine, which is neutral and polar, at codon 536 of the LIG4 protein (p.Ser536Asn). This variant is present in population databases (rs552242241, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with LIG4-related conditions. ClinVar contains an entry for this variant (Variation ID: 581350). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt LIG4 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Genetic Services Laboratory, |
RCV001816733 | SCV002068877 | uncertain significance | not specified | 2017-09-28 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000705150 | SCV003814602 | uncertain significance | DNA ligase IV deficiency | 2022-02-04 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV004792414 | SCV005409642 | uncertain significance | not provided | 2024-04-24 | criteria provided, single submitter | clinical testing | BP4 |